Talsaclidine in patients with dementia of Alzheimer type

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1999
The objective of this trial was to assess the dose-response relationship of symptomatic efficacy of talsaclidine base on ADAScog and to assess safety and tolerability
Epistemonikos ID: e2d4c7bb51ae5f0d4547d8846825a2b501475799
First added on: May 12, 2024